newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Announces Revised Long-Term Financial Guidance

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it has revised and updated the long-term financial guidance most recently included in its November 1, 2022 press release announcing its financial results for